Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling

Xu,Lixiu; Xu,Lixiu; Li,Jinqiu; Li,Jinqiu; Tursun,Mikrban; Tursun,Mikrban; Hai,Yan; Hai,Yan; Tursun,Hatila; Tursun,Hatila; Mamtimin,Batur; Mamtimin,Batur; Hasim,Ayshamgul; Hasim,Ayshamgul

doi:10.3892/ijo.2022.5373

Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling

Authors:
- Lixiu Xu
- Jinqiu Li
- Mikrban Tursun
- Yan Hai
- Hatila Tursun
- Batur Mamtimin
- Ayshamgul Hasim
View Affiliations

Affiliations: Department of Basic Medicine, Xinjiang Medical University and Xinjiang Key Laboratory of Molecular Biology of Endemic Diseases, Urumqi, Xinjiang 830017, P.R. China, Department of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang 830017, P.R. China
Published online on: May 24, 2022 https://doi.org/10.3892/ijo.2022.5373
Article Number: 83
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cervical cancer (CC), an aggressive form of squamous cell carcinoma, is characterized by early‑stage lymph node metastasis and an extremely poor prognosis. The authors have previously demonstrated that patients with CC have aberrant glycolysis. The upregulation of receptor for activated C kinase 1 (RACK1) is associated with CC lymph node metastasis (LNM). However, its role in mediating aerobic glycolysis in CC LNM remains unclear. In the present study, ¹H nuclear magnetic resonance analysis revealed a significant association between RACK1 expression and the glycolysis/gluconeogenesis pathway. Additionally, RACK1 knockdown inhibited aerobic glycolysis and lymphangiogenesis in vitro and suppressed CC LNM in vivo. Furthermore, protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling was identified as a critical RACK1‑regulated pathway that increased lymphangiogenesis in CC. Co‑immunoprecipitation, immunofluorescence and western blot analysis revealed that RACK1 activated AKT/mTOR signaling by interacting with insulin‑like growth factor 1 receptor (IGF1R). POU class 2 homeobox 2 (POU2F2) bound to the RACK1 promoter and regulated its transcription, thereby functionally contributing to glycolysis and lymphangiogenesis in CC. Of note, the administration of 2‑deoxy‑D‑glucose, which attenuates glycolysis, inhibited RACK1‑induced lymphangiogenesis in CC. The correlations between RACK1, IGF1R, POU2F2 and hexokinase 2 were further confirmed in CC tissues. Thus, RACK1 plays a crucial role in CC tumor LNM by regulating glycolysis via IGF1R/AKT/mTOR signaling. Thus, the targeting of the POU2F2/RACK1/IGF1R/AKT/mTOR signaling pathway may provide a novel treatment strategy for CC.

View Figures

View References

1	Kagabu M, Yoshino N, Saito T, Miura Y, Takeshita R, Murakami K, Kawamura H, Baba T and Sugiyama T: The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model. Int J Clin Oncol. 26:591–597. 2021. View Article : Google Scholar
2	Husaiyin S, Jiao Z, Yimamu K, Maisaidi R, Han L and Niyazi M: Thinprep cytology combined with hpv detection in the diagnosis of cervical lesions in 1622 patients. PLoS One. 16:e02609152021. View Article : Google Scholar
3	Yang H, Kuo YH, Smith ZI and Spangler J: Targeting cancer metastasis with antibody therapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 13. pp. e16982021, View Article : Google Scholar
4	Federico C, Sun J, Muz B, Alhallak K, Cosper PF, Muhammad N, Jeske A, Hinger A, Markovina S, Grigsby P, et al: Localized delivery of cisplatin to cervical cancer improves its therapeutic efficacy and minimizes its side effect profile. Int J Radiat Oncol Biol Phys. 109:1483–1494. 2021. View Article : Google Scholar
5	Swartz MA and Lund AW: Lymphatic and interstitial flow in the tumour microenvironment: Linking mechanobiology with immunity. Nat Rev Cancer. 12:210–219. 2012. View Article : Google Scholar
6	Fagiani E, Lorentz P, Bill R, Pavotbawan K, Kopfstein L and Christofori G: Vegf receptor-2-specific signaling mediated by vegf-e induces hemangioma-like lesions in normal and in malignant tissue. Angiogenesis. 19:339–358. 2016. View Article : Google Scholar
7	Liu D, Zeinolabediny Y, Caccuri F, Ferris G, Fang WH, Weston R, Krupinski J, Colombo L, Salmona M, Corpas R, et al: P17 from hiv induces brain endothelial cell angiogenesis through egfr-1-mediated cell signalling activation. Lab Invest. 99:180–190. 2019. View Article : Google Scholar
8	Park MK, Zhang L, Min KW, Cho JH, Yeh CC, Moon H, Hormaechea-Agulla D, Mun H, Ko S, Lee JW, et al: Neat1 is essential for metabolic changes that promote breast cancer growth and metastasis. Cell Metab. 33:2380–2397. 2021. View Article : Google Scholar
9	Vaupel P, Schmidberger H and Mayer A: The warburg effect: Essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 95:912–919. 2019. View Article : Google Scholar
10	Luo P, Zhang C, Liao F, Chen L, Liu Z, Long L, Jiang Z, Wang Y, Wang Z, Liu Z, et al: Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-myc mediated warburg effect. Cell Commun Signal. 17:362019. View Article : Google Scholar
11	Yang J, Ren B, Yang G, Wang H, Chen G, You L, Zhang T and Zhao Y: The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci. 77:305–321. 2020. View Article : Google Scholar
12	Hasim A, Ali M, Mamtimin B, Ma JQ, Li QZ and Abudula A: Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by (1)H NMR spectroscopy. Exp Ther Med. 3:945–951. 2012. View Article : Google Scholar
13	Wu J, Meng J, Du Y, Huang Y, Jin Y, Zhang J, Wang B, Zhang Y, Sun M and Tang J: Rack1 promotes the proliferation, migration and invasion capacity of mouse hepatocellular carcinoma cell line in vitro probably by pi3k/rac1 signaling pathway. Biomed Pharmacother. 67:313–319. 2013. View Article : Google Scholar
14	Wu H, Song S, Yan A, Guo X, Chang L, Xu L, Hu L, Kuang M, Liu B, He D, et al: Rack1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1. Cancer Lett. 469:287–300. 2020. View Article : Google Scholar
15	Tokunaga H, Shimada M, Ishikawa M and Yaegashi N: TNM classification of gynaecological malignant tumours, eighth edition: Changes between the seventh and eighth editions. Jpn J Clin Oncol. 49:311–320. 2019. View Article : Google Scholar
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
17	Liu D, Li C, Trojanowicz B, Li X, Shi D, Zhan C, Wang Z and Chen L: Cd97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent. Gastric Cancer. 19:754–766. 2016. View Article : Google Scholar
18	Cui B, Chen J, Luo M, Liu YY, Chen HL, Lü D, Wang LW, Kang YZ, Feng Y, Huang LB and Zhang P: PKD3 promotes metastasis and growth of oral squamous cell carcinoma through positive feedback regulation with PD-L1 and activation of ERK-STAT1/3-EMT signalling. Int J Oral Sci. 13:82021. View Article : Google Scholar
19	Bower AJ, Li J, Chaney EJ, Marjanovic M, Spillman DR Jr and Boppart SA: High-speed imaging of transient metabolic dynamics using two-photon fluorescence lifetime imaging microscopy. Optica. 5:1290–1296. 2018. View Article : Google Scholar
20	Li HM, Yang JG, Liu ZJ, Wang WM, Yu ZL, Ren JG, Chen G, Zhang W and Jia J: Blockage of glycolysis by targeting pfkfb3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 36:72017. View Article : Google Scholar
21	Wan J, Liu Y, Long F, Tian J and Zhang C: Circpvt1 promotes osteosarcoma glycolysis and metastasis by sponging mir-423-5p to activate wnt5a/ror2 signaling. Cancer Sci. 112:1707–1722. 2021. View Article : Google Scholar
22	Lenz G, Hamilton A, Geng S, Hong T, Kalkum M, Momand J, Kane SE and Huss JM: T-darpp activates igf-1r signaling to regulate glucose metabolism in trastuzumab-resistant breast cancer cells. Clin Cancer Res. 24:1216–1226. 2018. View Article : Google Scholar
23	Hermanto U, Zong CS, Li WQ and Wang LH: RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol Cell Biol. 22:2345–2365. 2002. View Article : Google Scholar
24	Zhang W, Zong CS, Hermanto U, Lopez-Bergami P, Ronai Z and Wang LH: Rack1 recruits stat3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage-independent growth. Mol Cell Biol. 26:413–424. 2006. View Article : Google Scholar
25	Lin T, Yang Y, Ye X, Yao J and Zhou H: Low expression of mir-99b promotes progression of clear cell renal cell carcinoma by up-regulating igf1r/akt/mtor signaling. Int J Clin Exp Pathol. 13:3083–3091. 2020.
26	Ellis BC, Graham LD and Molloy PL: Crnde, a long non-coding rna responsive to insulin/igf signaling, regulates genes involved in central metabolism. Biochim Biophys Acta. 1843:372–386. 2014. View Article : Google Scholar
27	Sun T, Liu Z and Yang Q: The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 19:1462020. View Article : Google Scholar
28	Zhou L and Xu XL: Long non-coding rna arap1-as1 facilitates the progression of cervical cancer by regulating mir-149-3p and pou2f2. Pathobiology. 88:301–312. 2021. View Article : Google Scholar
29	Yang R, Wang M, Zhang G, Li Y, Wang L and Cui H: Pou2f2 regulates glycolytic reprogramming and glioblastoma progression via pdpk1-dependent activation of pi3k/akt/mtor pathway. Cell Death Dis. 12:4332021. View Article : Google Scholar
30	Guler OC, Torun N, Yildirim BA and Onal C: Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy. Br J Radiol. 91:201705522018. View Article : Google Scholar
31	Cegla P, Burchardt E, Roszak A, Czepczynski R, Kubiak A and Cholewinski W: Influence of biological parameters assessed in [18f]fdg pet/ct on overall survival in cervical cancer patients. Clin Nucl Med. 44:860–863. 2019. View Article : Google Scholar
32	Osaku D, Komatsu H, Okawa M, Iida Y, Sato S, Oishi T and Harada T: Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 figo staging system. Taiwan J Obstet Gynecol. 60:1054–1058. 2021. View Article : Google Scholar
33	Duan F, Wu H, Jia D, Wu W, Ren S, Wang L, Song S, Guo X, Liu F, Ruan Y and Gu J: O-glcnacylation of rack1 promotes hepatocellular carcinogenesis. J Hepatol. 68:1191–1202. 2018. View Article : Google Scholar
34	Han H, Wang D, Yang M and Wang S: High expression of rack1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 15:2073–2078. 2018.
35	Wang J and Chen S: Rack1 promotes mir-302b/c/d-3p expression and inhibits ccno expression to induce cell apoptosis in cervical squamous cell carcinoma. Cancer Cell Int. 20:3852020. View Article : Google Scholar
36	Zhu X, Chen L, Liu L and Niu X: EMT-mediated acquired EGFR-TKI resistance in NSCLC: Mechanisms and strategies. Front Oncol. 9:10442019. View Article : Google Scholar
37	Mahmood MQ, Ward C, Muller HK, Sohal SS and Walters EH: Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): A mutual association with airway disease. Med Oncol. 34:452017. View Article : Google Scholar
38	Torresano L, Nuevo-Tapioles C, Santacatterina F and Cuezva JM: Metabolic reprogramming and disease progression in cancer patients. Biochim Biophys Acta Mol Basis Dis. 1866:1657212020. View Article : Google Scholar
39	Li S, Zhu K, Liu L, Gu J, Niu H and Guo J: Lncarsr sponges mir-34a-5p to promote colorectal cancer invasion and metastasis via hexokinase-1-mediated glycolysis. Cancer Sci. 111:3938–3952. 2020. View Article : Google Scholar
40	Liang J, Yang Y, Bai L, Li F and Li E: Drp1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis. J Gastroenterol Hepatol. 35:885–895. 2020. View Article : Google Scholar
41	Gong X, Tang H and Yang K: Per1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the per1/rack1/pi3k signaling complex. Cell Death Dis. 12:2762021. View Article : Google Scholar
42	Baserga R: The Igf-I receptor in cancer research. Exp Cell Res. 253:1–6. 1999. View Article : Google Scholar
43	Han L: Mir-99a inhibits proliferation and migration of cervical cancer cells by targeting igf1r. J BUON. 26:1782–1788. 2021.
44	Sin STK, Li Y, Liu M, Ma S and Guan XY: Trop-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of igf-1r and alk signaling. Gynecol Oncol. 152:185–193. 2019. View Article : Google Scholar
45	Kiely PA, Sant A and O'Connor R: Rack1 is an insulin-like growth factor 1 (igf-1) receptor-interacting protein that can regulate igf-1-mediated akt activation and protection from cell death. J Biol Chem. 277:22581–22589. 2002. View Article : Google Scholar
46	Caromile LA, Dortche K, Rahman MM, Grant CL, Stoddard C, Ferrer FA and Shapiro LH: Psma redirects cell survival signaling from the mapk to the pi3k-akt pathways to promote the progression of prostate cancer. Sci Signal. 10:eaag33262017. View Article : Google Scholar
47	He X, Wang J, Messing EM and Wu G: Regulation of receptor for activated c kinase 1 protein by the von hippellindau tumor suppressor in igf-i-induced renal carcinoma cell invasiveness. Oncogene. 30:535–547. 2011. View Article : Google Scholar
48	Wu Q, Ma J, Wei J, Meng W, Wang Y and Shi M: Foxd1-as1 regulates foxd1 translation and promotes gastric cancer progression and chemoresistance by activating the pi3k/akt/mtor pathway. Mol Oncol. 15:299–316. 2021. View Article : Google Scholar
49	Li ZQ, Qu M, Wan HX, Wang H, Deng Q and Zhang Y: Foxk1 promotes malignant progression of breast cancer by activating PI3K/AKT/MTOR signaling pathway. Eur Rev Med Pharmacol Sci. 23:9978–9987. 2019.
50	Zheng Y, Wu C, Yang J, Zhao Y, Jia H, Xue M, Xu D, Yang F, Fu D, Wang C, et al: Insulin-like growth factor 1-induced enolase 2 deacetylation by hdac3 promotes metastasis of pancreatic cancer. Signal Transduct Target Ther. 5:532020. View Article : Google Scholar
51	Wang SM, Tie J, Wang WL, Hu SJ, Yin JP, Yi XF, Tian ZH, Zhang XY, Li MB, Li ZS, et al: Pou2f2-oriented network promotes human gastric cancer metastasis. Gut. 65:117–1438. 2016. View Article : Google Scholar
52	Bentrari F, Chantôme A, Knights A, Jeannin JF and Pance A: Oct-2 forms a complex with oct-1 on the inos promoter and represses transcription by interfering with recruitment of rna polii by oct-1. Nucleic Acids Res. 43:9757–9765. 2015.